A new, bipartisan interest in tackling rising drug prices is rippling through the industry.
Trump's Focus on Drug Costs Jolts Big Pharma
Comment
Show comments
Hide Comments
A new, bipartisan interest in tackling rising drug prices is rippling through the industry.
